ALKEM LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,822 INR | +0.24% |
|
-11.55% | -7.31% |
| 30/05 | Alkem Laboratories' Consolidated Profit Soars in Fiscal Q4; Shares Slump 6% | MT |
| 30/05 | Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,200 From INR4,470, Keeps at Underperform | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 689.17Cr | ||||||
| 74TCr | ||||||
| 60TCr | ||||||
| 35TCr | ||||||
| 32TCr | ||||||
| 28TCr |
